ALAMEDA, Calif.--(BUSINESS WIRE)--Celera (NASDAQ:CRA) and its collaborators today announced the presentation of data demonstrating increased risk of myocardial infarction (MI), or heart attack, in carriers of the KIF6 gene variant in a case-control study of a Hispanic population from Costa Rica. The data will be presented as poster #P204 in session 3 at the American Heart Association’s 49TH Cardiovascular Disease Epidemiology and Prevention Conference in Palm Harbor, FL. This follows Celera’s recent findings from six prospective studies that report the association of a variant of the gene encoding kinesin-like protein 6 with coronary events in whites and African American populations(1-5).
